US 9617512
Derivation of embryonic stem cells and embryo-derived cells
granted A61KA61K35/12A61P
Quick answer
US patent 9617512 (Derivation of embryonic stem cells and embryo-derived cells) held by Astellas Institute for Regenerative Medicine expires Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Astellas Institute for Regenerative Medicine
- Grant date
- Tue Apr 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K35/12, A61P, A61P43/00